CD8A and neoplasm: Based on experimental and clinical research, radiation therapy (RT) may function as an in-situ cancer vaccine by immune-stimulating cell death, which releases antigens from the tumour and attracts CD8+ T cells to the location, increasing the tumour’s immunogenicity.